“We are already witnessing the result of AI and machine learning making an impact across industries and this is especially true for the pharmaceutical sector," says Karan Singh, Managing DIrector of ACG.
"As an example, ACG Capsule’s facility in Pithampur (India), which recently became part of the WEF Global Lighthouse Network, is already benefitting from its adoption of industrial internet of things (IIoT), machine learning (ML), deep learning (DL), digital twins, augmented reality and generative AI."
"ACG has demonstrated the accelerated deployment of GenAI to address the changing needs of employee skill sets in manufacturing; the company developed and deployed an SOP and policy interfacing GenAI assistant in just 2 weeks."
“In the coming year, we’ll see the impact of these fourth industrial revolution technologies step up pharmaceutical manufacturing even further — helping facilities to make the most of their workforce talent."
“Robotics and automation will extend the capabilities of teams, helping to deliver on the industry’s commitment to excellence and to operating facilities that are leading technological innovation through advanced manufacturing."
“The use of digital twins will become more widespread in product testing and optimisation ... as well as the reduction of material waste and storage costs."
"We’ll also see more adoption of Gen AI and robotics in factories; humans working side by side with machines to drive new ideas and innovation will make the industry safer, more efficient and more connected.”
